Floatz logo

Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules

Basal Ganglia Diseases

Beijing Friendship HospitalPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Basal Ganglia Diseases cohort.

Asset / SponsorPhaseRating
Live Combined Bifidobacterium
Beijing Friendship Hospital
Phase 4BB
Vy-Aadc01
Neurocrine Biosciences
Phase 1CC

Same molecule, other indications

Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules is also rated in:

neurodegenerative diseaseDormant
BB
Indicative ·
65 / 100
View asset →
movement disorderDormant
BB
Indicative ·
65 / 100
View asset →
central nervous system disorderDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →